Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

4.120 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Recursion Pharmaceuticals, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

23 24 Next >

Recursion Announces CEO Transition Plan to Drive Next Phase of Growth

November 05, 2025

Co-Founder and CEO Chris Gibson to Transition to Chairman of the Board; Najat Khan to be named Chief Executive Officer and President

From Recursion Pharmaceuticals

Via GlobeNewswire

Earnings Scheduled For November 5, 2025 ↗

November 05, 2025

Via Benzinga

AI Unleashes a New Era in Cell and Gene Therapy: A Quarter Century Update Reveals Transformative Potential

November 04, 2025

The burgeoning fields of cell and gene therapy (CGT) are on the cusp of a profound revolution, driven by the relentless advancements in artificial intelligence. This transformative impact was a central...

Via TokenRing AI

Topics Artificial Intelligence

Recursion Pharmaceuticals (RXRX) CEO Sells 100,000 Shares ↗

October 20, 2025

Via The Motley Fool

3 Things Investors Need to Know About Recursion Pharmaceuticals ↗

November 04, 2025

Can this under-the-radar stock be a great way to cash in on AI?

Via The Motley Fool

Topics Animal Testing Artificial Intelligence

Recursion to Participate in Upcoming Investor Conferences

November 04, 2025

From Recursion Pharmaceuticals

Via GlobeNewswire

The AI Imperative: Why Rapid Upskilling is Non-Negotiable for Pharma’s Future

October 31, 2025

The pharmaceutical sector stands at the precipice of a profound transformation, driven by the relentless march of artificial intelligence (AI) and other advanced technologies. As highlighted by...

Via TokenRing AI

Topics Artificial Intelligence Economy

AI Revolutionizes Pharma R&D: A New Era of Accelerated Drug Discovery and Personalized Medicine

October 31, 2025

Artificial intelligence (AI) is ushering in a transformative era for pharmaceutical research and development (R&D), fundamentally reshaping how new medicines are discovered, developed, and brought to...

Via TokenRing AI

Topics Artificial Intelligence Intellectual Property

Could Recursion Pharmaceuticals Be the Next Big Artificial Intelligence (AI) Stock? ↗

October 31, 2025

Recursion uses artificial intelligence to help advance drug discovery, which could be a massive opportunity in healthcare.

Via The Motley Fool

Topics Artificial Intelligence Economy

AI Revolutionizes Drug Discovery and Personalized Medicine: A New Era of Healthcare

October 22, 2025

The pharmaceutical and biotechnology industries are undergoing a profound transformation, driven by an urgent need for more efficient drug discovery and development processes and the paradigm shift...

Via TokenRing AI

Topics Animal Testing Artificial Intelligence

Recursion to Report Third Quarter 2025 Business Updates and Financial Results on November 5th

October 28, 2025

Company to host public (L)earnings call on November 5th at 8:00 am ET / 6:00 am MT / 1:00 pm GMT

From Recursion Pharmaceuticals

Via GlobeNewswire

Looking For The Next Beyond Meat? Here Are The Top 10 Most Shorted Stocks ↗

October 22, 2025

Here's a look at the most heavily shorted stocks in the market as investors look for the next Beyond Meat.

Via Benzinga

Short Squeeze Frenzy Fuels October's Market Rebound: A Closer Look at Bearish Bets and Bullish Surges

October 21, 2025

The U.S. stock market has staged a remarkable recovery in October 2025, with major indices reclaiming lost ground amidst a confluence of positive corporate earnings and improving macroeconomic...

Via MarketMinute

Topics Economy Stocks World Trade

Up 25% in 1 Month, Is This Stock a Buy? ↗

October 21, 2025

It might look like this beaten-down AI-focused company is finally bouncing back, but don't be too quick to pull the trigger.

Via The Motley Fool

Topics Animal Testing Artificial Intelligence

WW International, Replimune Group, Datavault AI, GRAIL And Other Big Stocks Moving Higher On Monday ↗

October 20, 2025

Via Benzinga

Topics Artificial Intelligence

3 Growth Stocks to Invest $1,000 in Right Now ↗

October 19, 2025

Not every promising prospect is currently priced too richly relative to its risk.

Via The Motley Fool

Most active stocks in Thursday's session ↗

October 16, 2025

Stay updated with the latest market activity on Thursday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight.

Via Chartmill

Is Recursion Pharmaceuticals a Millionaire Maker? ↗

October 16, 2025

This is the only biotech stock to attract an investment from artificial intelligence (AI) giant Nvidia.

Via The Motley Fool

Topics Artificial Intelligence Initial Public Offering

Morgan Stanley, T1 Energy, Bunge Global, Bank of America And Other Big Stocks Moving Higher On Wednesday ↗

October 15, 2025

Via Benzinga

AI Agents Usher in a New Era of Pharmaceutical Discovery: Accelerating Cures to Market

October 14, 2025

The pharmaceutical industry stands on the precipice of a revolutionary transformation, driven by the burgeoning power of artificial intelligence (AI) agents. These sophisticated, autonomous systems are...

Via TokenRing AI

Topics Artificial Intelligence Intellectual Property

Absci's AI Revolution: A New Era for Drug Discovery or a Rocky Road Ahead?

October 13, 2025

Absci (NASDAQ: ABSI), a pioneer in AI-driven drug discovery, is making significant strides with its "Integrated Drug Creation™ Platform," promising to revolutionize how new medicines are brought to...

Via MarketMinute

Topics Artificial Intelligence

2 Reasons Absci Could Be the Future of AI Biotech, and 1 Risk ↗

October 13, 2025

Absci's AI drug development platform is compelling, and its pipeline is promising...but can the company overcome execution hurdles to live up to analyst hype?

Via MarketBeat

Topics Artificial Intelligence

4 Healthcare Stocks to Buy Now ↗

October 12, 2025

As investors crowd into AI names at record highs, these three healthcare stocks offer more compelling valuations.

Via The Motley Fool

Topics Artificial Intelligence

Costco, AMD, Recursion Pharmaceuticals, Cipher Mining And Snowflake: Why These 5 Stocks Are On Investors' Radars Today ↗

October 08, 2025

On Wednesday, major U.S. indices closed mixed, with the Nasdaq rising 1.1% to 23,043.38 and the S&P 500 slipping nearly 0.6% to 6,753.72. The Dow Jones Industrial Average was unchanged at...

Via Benzinga

Topics Stocks

What's Going On With Recursion Pharmaceuticals Stock On Wednesday? ↗

October 08, 2025

Recursion Pharmaceuticals' stock rises on heavy trading volume, with investors eyeing its AI-designed cancer drug REC-3565 and extended cash runway.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

October 08, 2025

Via Benzinga

Dell, Select Medical, Century Aluminum And Other Big Stocks Moving Higher On Wednesday ↗

October 08, 2025

Via Benzinga

Decoding Life's Blueprint: New Tech Maps RNA-Protein Interactions, Unlocking Disease Cures

October 02, 2025

A monumental leap in biomedical research has been announced with the development of a breakthrough technology capable of mapping the entire intricate network of RNA-protein interactions within human...

Via MarketMinute

Topics Artificial Intelligence Derivatives

AI Revolutionizes Professional Services: A New Era for Doctors, Lawyers, and Consultants

October 01, 2025

As of October 1, 2025, Artificial Intelligence (AI) has transcended its nascent stages, becoming an indispensable force in high-value professional tasks across medicine, law, and consulting. This...

Via MarketMinute

Topics Artificial Intelligence

Nvidia Has Invested in These 6 Companies. Should You Follow Suit? ↗

September 29, 2025

The world's most valuable company holds stakes in a number of smaller tech players.

Via The Motley Fool

Topics Artificial Intelligence

< Previous 1 2 3 4 5 6 7 8 9

...

23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.